Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
Alexis CallowayRobin DalalDawn B BeaulieuCaroline DuleyKimberly AnnisLawrence GainesChris SlaughterDavid A SchwartzSara N HorstPublished in: Digestive diseases and sciences (2017)
Depressive symptoms at baseline were associated with medication noncompliance of anti-TNF therapies at follow-up when controlling for age, sex, disease type, and history of psychiatric disease.